80%Confidence
0Views
FDASource
2026-04-19Date
Summary
Dry eye relief products from K.C. Pharmaceuticals show sterility issues affecting multiple brands including Geri Care and Rite Aid. This pattern suggests fundamental quality control failures that may require manufacturing process overhaul.
Actionable: Assess alternative suppliers for dry eye relief products to mitigate supply chain risks.
AI Confidence: 80%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productDry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ (15 mL) bottles; a) GERI CARE, Distributed by:
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now